Search research articles
Contact Us
Filters
Showing results (41-50 of 125) with videos related to
Page
of 13
Sort By:
Clinical Nuclear Medicine
|
September 9, 2016
68Ga-PSMA-11 Dynamic PET/CT Imaging in Primary Prostate Cancer
Christos Sachpekidis, Klaus Kopka, Matthias Eder, et al.
BJU International
|
November 15, 2008
Paclitaxel incorporated in hydrophobically derivatized hyperbranched polyglycerols for intravesical bladder cancer therapy
Clement Mugabe, Boris A Hadaschik, Rajesh K Kainthan, et al.
Urologia Internationalis
|
April 18, 2023
MR-Guided Transurethral Ultrasound Ablation of Prostate Cancer: Initial Experience of Monitoring Tumor Response by Dynamic Apparent Diffusion Coefficient Measurements at 3.0 T
Lena Meyer, Andreas Bohlscheid, Oscar Lemmer, et al.
Advances in Therapy
|
November 19, 2021
Apalutamide Compared with Darolutamide for the Treatment of Non-metastatic Castration-Resistant Prostate Cancer: Efficacy and Tolerability in a Matching-Adjusted Indirect Comparison
Simon Chowdhury, Stephane Oudard, Hiroji Uemura, et al.
Advances in Anatomic Pathology
|
October 12, 2022
Immune-Checkpoint-Inhibitor Therapy-Principles and Relevance of Biomarkers for Pathologists and Oncologists
Christopher Darr, Thomas Hilser, Claudia Kesch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 8, 2017
The Clinical Impact of Additional Late PET/CT Imaging with <sup>68</sup>Ga-PSMA-11 (HBED-CC) in the Diagnosis of Prostate Cancer
Ali Afshar-Oromieh, Lars Peter Sattler, Walter Mier, et al.
BJU International
|
August 14, 2013
Histology core-specific evaluation of the European Society of Urogenital Radiology (ESUR) standardised scoring system of multiparametric magnetic resonance imaging (mpMRI) of the prostate
Timur H Kuru, Matthias C Roethke, Philip Rieker, et al.
Urologie (Heidelberg, Germany)
|
March 21, 2023
[Systematic or targeted fusion-guided biopsy]
Analena Elisa Handke, Peter Albers, Lars Schimmöller, et al.
Cancer Research
|
June 19, 2008
Oncolytic vesicular stomatitis viruses are potent agents for intravesical treatment of high-risk bladder cancer
Boris A Hadaschik, Kaixin Zhang, Alan I So, et al.
BJU International
|
April 4, 2008
Paclitaxel and cisplatin as intravesical agents against non-muscle-invasive bladder cancer
Boris A Hadaschik, Melanie G ter Borg, John Jackson, et al.
Page
of 13
Search research articles
Search
Showing results (41-50 of 125) with videos related to
Sort By:
Page
of 13
Clinical Nuclear Medicine
|
September 9, 2016
68Ga-PSMA-11 Dynamic PET/CT Imaging in Primary Prostate Cancer
Christos Sachpekidis, Klaus Kopka, Matthias Eder, et al.
BJU International
|
November 15, 2008
Paclitaxel incorporated in hydrophobically derivatized hyperbranched polyglycerols for intravesical bladder cancer therapy
Clement Mugabe, Boris A Hadaschik, Rajesh K Kainthan, et al.
Urologia Internationalis
|
April 18, 2023
MR-Guided Transurethral Ultrasound Ablation of Prostate Cancer: Initial Experience of Monitoring Tumor Response by Dynamic Apparent Diffusion Coefficient Measurements at 3.0 T
Lena Meyer, Andreas Bohlscheid, Oscar Lemmer, et al.
Advances in Therapy
|
November 19, 2021
Apalutamide Compared with Darolutamide for the Treatment of Non-metastatic Castration-Resistant Prostate Cancer: Efficacy and Tolerability in a Matching-Adjusted Indirect Comparison
Simon Chowdhury, Stephane Oudard, Hiroji Uemura, et al.
Advances in Anatomic Pathology
|
October 12, 2022
Immune-Checkpoint-Inhibitor Therapy-Principles and Relevance of Biomarkers for Pathologists and Oncologists
Christopher Darr, Thomas Hilser, Claudia Kesch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 8, 2017
The Clinical Impact of Additional Late PET/CT Imaging with <sup>68</sup>Ga-PSMA-11 (HBED-CC) in the Diagnosis of Prostate Cancer
Ali Afshar-Oromieh, Lars Peter Sattler, Walter Mier, et al.
BJU International
|
August 14, 2013
Histology core-specific evaluation of the European Society of Urogenital Radiology (ESUR) standardised scoring system of multiparametric magnetic resonance imaging (mpMRI) of the prostate
Timur H Kuru, Matthias C Roethke, Philip Rieker, et al.
Urologie (Heidelberg, Germany)
|
March 21, 2023
[Systematic or targeted fusion-guided biopsy]
Analena Elisa Handke, Peter Albers, Lars Schimmöller, et al.
Cancer Research
|
June 19, 2008
Oncolytic vesicular stomatitis viruses are potent agents for intravesical treatment of high-risk bladder cancer
Boris A Hadaschik, Kaixin Zhang, Alan I So, et al.
BJU International
|
April 4, 2008
Paclitaxel and cisplatin as intravesical agents against non-muscle-invasive bladder cancer
Boris A Hadaschik, Melanie G ter Borg, John Jackson, et al.
Page
of 13